Chiesi USA, Inc. FDA Inspection Record
Chiesi USA, Inc. is an FDA-inspected facility (FEI 3006389494) located in Cary, NC, US. RegDataLab tracks 9 FDA inspections and 3 compliance actions at this facility.
What FDA found at this site
- Latest inspection
- Aug 26, 2026: No Action Indicated (NAI)
- Inspections on record
- 9 (1 OAI, 1 VAI, 7 NAI)
- Last OAI inspection
- Mar 24, 2010
- Warning letters
- 3 listed by FDA for this FEI, latest Jun 22, 2010
- Recalls as the recalling firm
- 4, latest Aug 19, 2026
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Aug 26, 2026 | No Action Indicated (NAI) | No citations listed |
| Aug 1, 2024 | No Action Indicated (NAI) | No citations listed |
| Jun 15, 2018 | No Action Indicated (NAI) | No citations listed |
| Mar 6, 2015 | No Action Indicated (NAI) | No citations listed |
| Mar 4, 2015 | No Action Indicated (NAI) | No citations listed |
| Sep 20, 2012 | No Action Indicated (NAI) | No citations listed |
| Jul 24, 2012 | No Action Indicated (NAI) | No citations listed |
| Mar 24, 2010 | Official Action Indicated (OAI) | Rejecting When Specifications Not Met (21 CFR 211.84(e)) Complaint Handling Procedure (21 CFR 211.198(a)) Procedure Deviations Recorded and Justified (21 CFR 211.100(b)) Control procedures to monitor and validate performance (21 CFR 211.110(a)) and 1 more |
| Apr 28, 2009 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Control procedures to monitor and validate performance (21 CFR 211.110(a)) Contamination, chemical or physical change, deterioration (21 CFR 314.81(b)(1)(ii)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Aug 19, 2026 | Class III | D-0838-2026 | Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx… Failed Stability Specifications: Out of specification stability result for the protein concentration profile. |
| Jul 6, 2026 | Class II | D-0689-2026 | CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials… Lack of Assurance of Sterility |
| Mar 17, 2026 | Class II | D-0402-2026 | CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only… Lack of Assurance of Sterility |
| May 31, 2019 | Class II | D-1341-2019 | ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only… and 1 more product Failed Dissolution Specifications: Out of specification result for dissolution. |
FDA record score
9 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
8 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall D-0689-2026, this FEI as the recalling firm | Jul 6, 2026 | 4 x 1 | 4 |
| Class II recall D-0402-2026, this FEI as the recalling firm | Mar 17, 2026 | 4 x 1 | 4 |
| Class II recall D-1341-2019, this FEI as the recalling firm | May 31, 2019 | 4 x 0.25 | 1 |
| Warning letter on FDA's dashboard, which does not show close-outs | Jun 22, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Mar 24, 2010 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Nov 13, 2009 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | May 4, 2009 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Apr 28, 2009 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Chiesi USA, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Chiesi USA, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Chiesi USA, Inc.
- Location
- Cary, NC (US)
- Source
- inspections